Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.

Figlin, R A; deKernion, J B; Mukamel, E; Palleroni, A V; Itri, L M; Sarna, G P

Figlin, R A; deKernion, J B; Mukamel, E; Palleroni, A V; Itri, L M; Sarna, G P.

Affiliation

Figlin RA; Department of Medicine, UCLA School of Medicine.

J Clin Oncol ; 6(10): 1604-10, 1988 Oct.

Article in En | MEDLINE | ID: mdl-3049952

Subject(s)

Autoantibodies/analysis; Carcinoma, Renal Cell/secondary; Interferon Type I/therapeutic use; Interferon-alpha/therapeutic use; Kidney Neoplasms; Adult; Aged; Carcinoma, Renal Cell/immunology; Carcinoma, Renal Cell/therapy; Female; Humans; Immunoenzyme Techniques; Interferon alpha-2; Interferon-alpha/adverse effects; Interferon-alpha/immunology; Kidney Neoplasms/immunology; Male; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Remission Induction; Time Factors

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Autoantibodies / Carcinoma, Renal Cell / Interferon Type I / Interferon-alpha / Kidney Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 1988 Type: Article

Search on Google

XML

PubMed Links